Gastroenterology
Volume 135, Issue 3 , Pages 770-780 , September 2008

Folate and Vitamin B6 Intake and Risk of Colon Cancer in Relation to p53 Expression

  • Eva S. Schernhammer

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Ludwig Boltzmann Institute for Applied Cancer Research, KFJ-Spital, Vienna, Austria
    • Applied Cancer Research - Institute for Translational Research Vienna, Vienna, Austria
    • Corresponding Author InformationAddress requests for reprints to: Eva S. Schernhammer, MD, DrPH, Channing Laboratory, 181 Longwood Avenue, Boston, Massachusetts 02115. fax: (617) 525-2008
    • ,
  • Shuji Ogino

      Affiliations

    • Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts
    • ,
  • Charles S. Fuchs

      Affiliations

    • Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts
    • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts

Received 21 November 2007 ,Accepted 5 June 2008.

References 

  1. Kim YI. Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen. 2004;44:10–25
  2. Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132:2350S–2355S
  3. Harnack L, Jacobs DR, Nicodemus K, et al. Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2002;43:152–158
  4. Ulrich CM. Folate and cancer prevention: a closer look at a complex picture. Am J Clin Nutr. 2007;86:271–273
  5. Kim YI, Shirwadkar S, Choi SW, et al. Effects of dietary folate on DNA strand breaks within mutation-prone exons of the p53 gene in rat colon. Gastroenterology. 2000;119:151–161
  6. Crott JW, Choi SW, Ordovas JM, et al. Effects of dietary folate and aging on gene expression in the colonic mucosa of rats: implications for carcinogenesis. Carcinogenesis. 2004;25:69–76
  7. Sohn KJ, Stempak JM, Reid S, et al. The effect of dietary folate on genomic and p53-specific DNA methylation in rat colon. Carcinogenesis. 2003;24:81–90
  8. Crott JW, Liu Z, Keyes MK, et al. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. J Nutr Biochem. 2008;19:328–335
  9. Crott JW, Liu Z, Choi SW, et al. Folate depletion in human lymphocytes up-regulates p53 expression despite marked induction of strand breaks in exons 5–8 of the gene. Mutat Res. 2007;626:171–179
  10. Wasson GR, McGlynn AP, McNulty H, et al. Global DNA and p53 region-specific hypomethylation in human colonic cells is induced by folate depletion and reversed by folate supplementation. J Nutr. 2006;136:2748–2753
  11. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532
  12. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990;50:7717–7722
  13. Hollstein M, Rice K, Greenblatt MS, et al. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res. 1994;22:3551–3555
  14. Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med. 1998;129:517–524
  15. Chen J, Giovannucci E, Hankinson SE, et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis. 1998;19:2129–2132
  16. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65
  17. Giovannucci E, Stampfer MJ, Colditz GA, et al. Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst. 1993;85:875–884
  18. Willett WC, Sampson L, Browne ML, et al. The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol. 1988;127:188–199
  19. Willett WC, Stampfer MJ, Colditz GA, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med. 1987;316:1174–1180
  20. Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119:837–839
  21. Melhem MF, Law JC, el-Ashmawy L, et al. Assessment of sensitivity and specificity of immunohistochemical staining of p53 in lung and head and neck cancers. Am J Pathol. 1995;146:1170–1177
  22. Nishio M, Koshikawa T, Kuroishi T, et al. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J Clin Oncol. 1996;14:497–502
  23. Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 1994;54:4855–4878
  24. Ogino S, Brahmandam M, Kawasaki T, et al. Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. Neoplasia. 2006;8:458–464
  25. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest. 2000;80:1943–1949
  26. Ogino S, Kawasaki T, Kirkner GJ, et al. Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol. 2007;20:15–22
  27. Hall PA, McCluggage WG. Assessing p53 in clinical contexts: unlearned lessons and new perspectives. J Pathol. 2006;208:1–6
  28. Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006;19:59–68
  29. Curtin K, Slattery ML, Holubkov R, et al. p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry. Appl Immunohistochem Mol Morphol. 2004;12:380–386
  30. de Jong KP, Gouw AS, Peeters PM, et al. P53 mutation analysis of colorectal liver metastases: relation to actual survival, angiogenic status, and p53 overexpression. Clin Cancer Res. 2005;11:4067–4073
  31. Hu FB, Stampfer MJ, Rimm E, et al. Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol. 1999;149:531–540
  32. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics. 1995;51:524–532
  33. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162:975–982
  34. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med. 1989;8:551–561
  35. Wei EK, Giovannucci E, Selhub J, et al. Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst. 2005;97:684–692
  36. Fuchs CS, Willett WC, Colditz GA, et al. The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev. 2002;11:227–234
  37. Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine–low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst. 1995;87:265–273
  38. Ulrich CM, Potter JD. Folate supplementation: too much of a good thing?. Cancer Epidemiol Biomarkers Prev. 2006;15:189–193
  39. Slattery ML, Curtin K, Ma K, et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev. 2002;11:541–548
  40. Lashner BA, Shapiro BD, Husain A, et al. Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis. Am J Gastroenterol. 1999;94:456–462
  41. Ulrich CM, Potter JD. Folate and cancer—timing is everything. JAMA. 2007;297:2408–2409
  42. Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351–2359
  43. Mason JB, Dickstein A, Jacques PF, et al. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16:1325–1329
  44. Food and Drug Administration. Food standards: amendment of standards of identity ro enriched grain products to require addition of folic acid (Final rule). Fed Register. 1996;8797–8807
  45. Ghavam-Nasiri MR, Rezaei E, Ghafarzadegan K, et al. Expression of p53 in colorectal carcinoma: correlation with clinicopathologic features. Arch Iran Med. 2007;10:38–42

 Supported by National Institutes of Health research grants CA70817, CA87969, CA55075, CA42812, CA58684, and CA90598 and the Lustgarten Foundation for Pancreatic Cancer Research as well as the Bennett Family Fund and Entertainment Industry Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

 The authors declare no conflict of interest relevant to this article.

PII: S0016-5085(08)01079-2

doi: 10.1053/j.gastro.2008.06.033

Gastroenterology
Volume 135, Issue 3 , Pages 770-780 , September 2008

Article Tools

* Image Usage & Resolution